ELISE GRENIER: Open Payments
NPI 1184634800 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,981 in 21 payments from 10 companies in 2025. Trend: 2023 $963 · 2024 $414 · 2025 $1,981
Consulting: $1,313Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $1,378 |
| Gilead Sciences, Inc. | 5 | $194 |
| Indivior Inc. | 1 | $130 |
| PFIZER INC. | 3 | $80 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| Lilly USA, LLC | 2 | $53 |
| Exeltis, USA Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $23 |
| SANOFI PASTEUR INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: QULIPTA, SUBLOCADE, Yeztugo, NURTEC ODT, MOUNJARO, GARDASIL 9, SLYND, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
